Navigation Links
Raydiance collaborates with Rutgers, MTF to develop innovative tissue processing approaches
Date:11/19/2007

Petaluma, CA and New Brunswick, NJ, November 19, 2007 Raydiance, Inc. today announced that is has entered into an innovative collaboration with Rutgers University and the Musculoskeletal Transplant Foundation (MTF), the nations largest tissue bank, to improve the science of dermal tissue processing.

In a first-of-its-kind test, world leading tissue engineers will utilize a new type of laser developed on the Raydiance Ultrashort Pulse (USP) laser platform to maximize the transplants processed from donated dermal tissue. As part of this process, the collaboration will explore new ways to use the transformational power and precision of the Raydiance laser, which can instantly vaporize material without heat or residual damage at very precise scales, down to a resolution of several microns.

The collaboration involves MTF as the project sponsor, Rutgers as the center for developing innovative tissue processing approaches and Raydiance as the core laser technology provider. Experts from all three parties will work towards providing more advanced technology that results in less expensive and faster solutions for those in need of skin transplants for burn, complicated hernia repair, and reconstructive procedures.

Dr. Zhixiong (James) Guo, principal investigator for Rutgers University, said, Having worked with lasers for years, the Raydiance laser platform is one hundred times more powerful than anything I have ever used before. Not only can it separate skin more precisely and effectively, but also it has the unique capability to decontaminate the surface of soft tissue. If our tests prove successful, we will be able to disrupt and reinvent dermal tissue processing as we know it. This is great news for burn victims as well as those suffering from cancer, degenerative joint disease, arthritis and other skin trauma.

Bruce Stroever, President and CEO of MTF, said Over 900,000 Americans receive tissue transplants each year, but m
'/>"/>

Contact: Carl Blesch
cblesch@ur.rutgers.edu
732-932-7084 x616
Rutgers University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Gender, coupled with diabetes, affects vascular disease development
2. New target for anti-flu drug development
3. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
4. A new radiation therapy treatment developed for head and neck cancer patients
5. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
6. Princeton engineers develop low-cost recipe for patterning microchips
7. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
8. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
9. UCR engineers to develop new tool to measure how environmental exposures affect health
10. Researchers develop simple method to create natural drug products
11. Researchers developing device to predict proper light exposure for human health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... -- CIE San Diego has launched an innovative trust ... that enhances care coordination among social service and care ... earned a second $1 million grant from the Alliance ... in community and; will be recognized as a "Live ... 4-6p. CIE San Diego today announced the ...
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
(Date:12/3/2014)...   Marvin Test Solutions , a trusted ... military, aerospace, and manufacturing organizations, today announced the ... TS-900 PXI semiconductor test platform . The TS-960 ... to customers at a fraction of the footprint ... "Our semiconductor customers asked for ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... Houston Cullen College of Engineering has won a grant to ... disease safer and more effective. The grant goes to ... the National Science Foundation, it is valued at $330,000 for ... Abosch, an M.D./Ph.D a neurosurgeon with the University of Colorado ...
... more than a decade PETA and its affiliates ... organisations worldwide, providing the European Union (EU) and ... with technical expertise in modern, reliable, non-animal research ... PETA US, PETA UK and their European and ...
... that individuals with the highest metabolic rates within populations ... changes in their environments that could lead them to ... however should be constantly monitoring their opportunities for higher ... shows that variation in metabolic rates between individuals can ...
Cached Biology News:Parkinson's Surgery Research wins NSF Grant 2PETA and its international affiliates launch not-for-profit international science company 2Gathering information about food is not top priority for individuals with high metabolisms 2
(Date:12/24/2014)... 2014 The report expects global cell ... 2019. It also provides a carefully analyzed data about ... for the market. , Full Copy of Report @ ... global market for cell expansion will keep witnessing growth ... this growth to be driven by rapid technological advancements, ...
(Date:12/24/2014)... Dec. 23, 2014 China Biologic Products, ... a leading fully integrated plasma-based biopharmaceutical company in ... its majority-owned subsidiary, Shandong Taibang Biological Products Co. ... from the China Food and Drug Administration (the ... As previously disclosed in the Company,s public filings, ...
(Date:12/24/2014)... -- PharmaBoardroom,s new report, , Healthcare ... for free download , digs deep into this vibrant ... the sector today. One area where ... developing a homegrown pharmaceutical manufacturing base, even if the government,s ... way off. A cursory comparison with neighboring Morocco ...
(Date:12/24/2014)... , Dec. 23, 2014  Rock Creek Pharmaceuticals, ... it has filed a Clinical Trial Application (CTA) with ... products Regulatory Agency (MHRA) seeking regulatory approval to initiate ... molecule, Anatabine Citrate. Contingent on the Company ... a Phase I trial to assess the safety, tolerability ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... Oxford Biomedica,s,second attempt to dismiss Bavarian Nordic,s patent ... denying infringement, Oxford Biomedica,made yet another attempt to dismiss ... still evaluated in clinical trials. The court ruled,against Oxford ... the,substance of the patents. , ...
... 8 Sinovac Biotech Ltd. (Amex: SVA ), ... it will host a conference call on Friday, May 15, ... quarter financial results for the period ended March 31, 2009 ... conference call, please dial 1-877-407-4018 (USA) or 1-201-689-8471 (international). ...
... (Nasdaq: NVAX) today announced financial results for ... of $8.3 million, or $0.12 per share, for the first quarter ... $0.13 per share, for the first quarter of 2008. The ... of 2009 and ended the quarter with $25.6 million in cash ...
Cached Biology Technology:The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica 2Sinovac to Host Conference Call to Report First Quarter 2009 Financial Results 2Novavax Reports First Quarter 2009 Financial Results 2Novavax Reports First Quarter 2009 Financial Results 3Novavax Reports First Quarter 2009 Financial Results 4Novavax Reports First Quarter 2009 Financial Results 5Novavax Reports First Quarter 2009 Financial Results 6Novavax Reports First Quarter 2009 Financial Results 7Novavax Reports First Quarter 2009 Financial Results 8
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
... monitoring Aldolase tests. 2 levels of ... manufacturing values at 4 ± 2 ... 30-day shelf life once opened ... 1: 3 x 3 ml; Level ...
Human VEGF-D Biotinylated MAb (Clone 78923)...
Mouse Wnt-11 Affinity Purified Polyclonal Ab...
Biology Products: